Myc Proto Oncogene Protein Global Market Report 2025
상품코드:1769666
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
마이코 프로토 종양유전자 단백질 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 이러한 미래의 성장은 표적 암 치료에 대한 관심 증가, 종양학 연구에 대한 자금 지원 확대, 맞춤형 의약품에 대한 수요 증가, Myc 억제제에 대한 임상 시험 확대, 첨단 시퀀싱 기술에 대한 접근성 확대에 기인할 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 유전자 발현 분석 기술의 발전, 의약품 전달 시스템의 혁신, 바이오마커 발견에 인공 지능의 사용, 펩타이드 기반 치료제 연구, 종양학 연구에 멀티 오믹스 플랫폼의 채택 등이 있습니다.
임상 시험의 수가 증가함에 따라 앞으로 마이코 프로토 종양유전자 단백질 시장의 성장이 가속화될 것으로 예상됩니다. 임상 시험은 새로운 의료 치료법이나 중재의 안전성과 효과를 평가하기 위해 인간을 대상으로 진행하는 연구입니다. 임상 시험의 양이 증가하는 것은 효과적인 치료법 개발을 가속화하고, 강력한 안전성 데이터를 생성하며, 환자에게 혁신적인 치료법을 더 빠르게 제공하고자 하는 연구자와 기업에 의해 촉진되고 있습니다. 이러한 임상 시험은 효능, 안전성 및 저항 메커니즘을 평가하여 마이코 프로토 종양유전자 단백질에 의한 암에 대한 표적 치료법을 평가하는 데 도움이 되며, 이를 통해 Myc 억제제 및 병용 치료법의 개발을 안내합니다. 예를 들어, 미국에 기반을 둔 과학 연구 국제 정보 기관인 국립 생명공학 정보 센터(National Center for Biotechnology Information)에 따르면, 2025년 6월 등록된 연구 건수는 2022년 43만 7,497건에서 2024년 52만 885건으로 증가했습니다. 따라서 임상 시험 건수의 증가는 마이코 프로토 종양유전자 단백질 시장의 성장을 촉진하고 있습니다.
암의 발생률 증가가 향후 마이코 프로토 종양유전자 단백질 시장 성장을 촉진할 것으로 예상됩니다. 암은 세포가 무절제하게 증식하고 다른 조직으로 침투할 수 있는 질환입니다. 암 환자의 증가세는 주로 고령화 인구 증가에 기인하며, 노인층은 이 질환에 더 취약합니다. 암은 Myc 단백질과 밀접하게 연관되어 있으며, 이 단백질의 과발현은 종양에서 자주 관찰되어 효과적인 치료법 개발의 유망한 표적으로 부상하고 있습니다. 예를 들어, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)에 따르면 2024년 2월, 2050년까지 3,500만 건 이상의 새로운 암 사례가 발생할 것으로 예상되며, 이는 2022년 예상치인 2,000만 건에 비해 77% 증가한 수치입니다. 따라서 암의 유병률이 증가하면서 마이코 프로토 종양유전자 단백질 시장의 성장을 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 마이코 프로토 종양유전자 단백질 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 마이코 프로토 종양유전자 단백질 시장 : 성장률 분석
세계의 마이코 프로토 종양유전자 단백질 시장 실적 : 규모와 성장(2019-2024년)
세계의 마이코 프로토 종양유전자 단백질 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 마이코 프로토 종양유전자 단백질 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 마이코 프로토 종양유전자 단백질 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
단일클론항체
재조합 단백질
중합효소 연쇄반응(PCR) 키트
효소 면역 측정(ELISA) 키트
세계의 마이코 프로토 종양유전자 단백질 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
BGA-003
ES-4000
갈라르민
기타 유형
세계의 마이코 프로토 종양유전자 단백질 시장 : 기술별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
유전자 발현 프로파일링
크로마틴 면역침전 시퀀싱(ChIP-Seq)
차세대 시퀀싱(NGS)
리보 핵산 간섭법
세계의 마이코 프로토 종양유전자 단백질 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
암 조사
진단
치료의 개발
바이오마커의 발견
세계의 마이코 프로토 종양유전자 단백질 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
학술연구기관
생명 공학 기업
제약회사
병원 및 진단실험실
세계의 마이코 프로토 종양유전자 단백질 시장 : 단일클론항체 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
치료용 단일클론항체
진단용 단일클론항체
연구 등급의 단일클론항체
세계의 마이코 프로토 종양유전자 단백질 시장 : 재조합 단백질 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
재조합 Myc 단백질
재조합 융합 단백질
재조합 항체 단편
세계의 마이코 프로토 종양유전자 단백질 시장 : 중합효소 연쇄반응(PCR) 키트 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정량 PCR(Qpcr) 키트
역전사 PCR(Rt-PCR) 키트
디지털 PCR 키트
세계의 마이코 프로토 종양유전자 단백질 시장 : 효소 면역 측정(ELISA) 키트 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
샌드위치 ELISA 키트
경쟁 ELISA 키트
간접 ELISA 키트
제7장 지역별, 국가별 분석
세계의 마이코 프로토 종양유전자 단백질 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 마이코 프로토 종양유전자 단백질 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
마이코 프로토 종양유전자 단백질 시장 : 경쟁 구도
마이코 프로토 종양유전자 단백질 시장 : 기업 프로파일
Arvinas Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
Arrakis Therapeutics Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
RayBiotech Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
Erasca Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
Anima Biotech Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
RDP Pharma AG
Peptomyc Sociedad Limitada
Kintor Pharmaceutical Limited
Immunostep Biotech
Cothera Bioscience Proprietary Limited
Escend Pharmaceuticals Incorporated
Gibson Oncology Limited Liability Company
MecRx Proprietary Limited
Moleculin Biotech Incorporated
Escend Pharmaceuticals Incorporated
Linnane Pharma Aktiebolag
PYC Therapeutics Limited
Sapience Therapeutics Incorporated
Peptomyc Sociedad Limitad
Aptose Biosciences Incorporated
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
마이코 프로토 종양유전자 단백질 시장(2029년) : 새로운 기회를 제공하는 국가
마이코 프로토 종양유전자 단백질 시장(2029년) : 새로운 기회를 제공하는 부문
마이코 프로토 종양유전자 단백질 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
The Myc proto-oncogene protein is a transcription factor that plays a vital role in cell cycle progression, apoptosis, and cellular transformation. It is encoded by the myc gene and regulates the expression of numerous genes involved in cell growth and proliferation. Abnormal overexpression or mutation of myc is linked to the development of various cancers.
The primary product types in the Myc proto-oncogene protein market include monoclonal antibodies, recombinant proteins, polymerase chain reaction (PCR) kits, and enzyme-linked immunosorbent assay (ELISA) kits. Monoclonal antibodies are laboratory-generated proteins that are identical copies of a single antibody, specifically designed to bind to a unique antigen, helping the immune system target and destroy specific cells or substances. Key types include BGA-003, ES-4000, Galarmin, and others. The technologies employed in this field include gene expression profiling, chromatin immunoprecipitation sequencing (ChIP-Seq), next-generation sequencing (NGS), and RNA interference techniques. These products are applied in cancer research, diagnostics, treatment development, and biomarker discovery, serving crucial needs in oncology and molecular biology. The primary end-users include academic and research institutions, biotechnology companies, pharmaceutical firms, and hospitals and diagnostic laboratories.
The myc proto oncogene protein market research report is one of a series of new reports from The Business Research Company that provides myc proto oncogene protein market statistics, including the myc proto oncogene protein industry global market size, regional shares, competitors with the myc proto oncogene protein market share, detailed myc proto oncogene protein market segments, market trends, and opportunities, and any further data you may need to thrive in the myc proto oncogene protein industry. This myc proto oncogene protein market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The myc proto-oncogene protein market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.90 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. Growth during the historical period was driven by the rising global incidence of cancer, greater adoption of biomarker-based diagnostics, increased academic research into transcription factors, expansion of oncology drug discovery efforts, and growing use of monoclonal antibodies in cancer detection.
The myc proto-oncogene protein market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. This future growth is anticipated to result from a heightened focus on targeted cancer therapies, increased funding for oncology research, a growing demand for personalized medicine, expanding clinical trials for myc inhibitors, and wider access to advanced sequencing technologies. Key trends expected during the forecast period include advances in gene expression analysis technologies, innovations in drug delivery systems, the use of artificial intelligence in biomarker discovery, research into peptide-based therapeutics, and the adoption of multi-omics platforms in oncology research.
The increasing number of clinical trials is expected to propel the growth of the myc proto oncogene protein market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments or interventions. The growing volume of clinical trials is driven by researchers and companies aiming to accelerate the development of effective therapies, generate robust safety data, and deliver innovative treatments to patients more quickly. These trials help assess targeted therapies against myc proto-oncogene-driven cancers by evaluating efficacy, safety, and resistance mechanisms, thereby guiding the development of MYC inhibitors and combination treatments. For instance, in June 2025, according to the National Center for Biotechnology Information, a US-based international resource for scientific research, the number of registered studies rose from 437,497 in 2022 to 520,885 in 2024. Therefore, the increasing number of clinical trials is driving the growth of the myc proto oncogene protein market.
The increasing prevalence of cancer is expected to propel the growth of the myc proto oncogene protein market going forward. Cancer is a condition in which cells multiply uncontrollably and may invade other tissues. The rising number of cancer cases is largely attributed to an aging population, as older individuals are more susceptible to developing the disease. Cancer is strongly linked to the MYC protein, whose overexpression is frequently observed in tumors, making it a promising target for the development of effective therapies. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 35 million new cancer cases were projected by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the myc proto oncogene protein market.
Major companies operating in the myc proto oncogene protein market are increasingly focusing on advanced therapeutics, such as myc-targeting peptide therapeutics, to revolutionize cancer treatment. A myc-targeting peptide therapeutic is a novel class of drug developed to inhibit the myc oncogene, which is abnormally activated in the majority of cancers and plays a key role in tumor growth and progression. For instance, in January 2025, Peptomyc S.L., a Spain-based biotechnology company, initiated a new Phase 2 clinical trial for its myc-inhibitor drug OMO-103 in patients with advanced osteosarcoma. OMO-103 is a first-in-class myc-targeting peptide designed to disrupt myc function in cancer cells, demonstrating a manageable safety profile and notable anti-tumor activity. This trial aims to evaluate the drug's clinical efficacy, safety, and pharmacodynamics, representing a significant advancement in targeted therapies for hard-to-treat cancers such as osteosarcoma.
Major players in the myc proto oncogene protein market are Arvinas Incorporated, Arrakis Therapeutics Incorporated, RayBiotech Incorporated, Erasca Incorporated, Anima Biotech Incorporated, RDP Pharma AG, Peptomyc Sociedad Limitada, Kintor Pharmaceutical Limited, Immunostep Biotech, Cothera Bioscience Proprietary Limited, Escend Pharmaceuticals Incorporated, Gibson Oncology Limited Liability Company, MecRx Proprietary Limited, Moleculin Biotech Incorporated, Escend Pharmaceuticals Incorporated, Linnane Pharma Aktiebolag, PYC Therapeutics Limited, Sapience Therapeutics Incorporated, Peptomyc Sociedad Limitad, and Aptose Biosciences Incorporated.
North America was the largest region in the myc proto oncogene protein market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myc proto oncogene protein report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the myc proto oncogene protein market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The myc proto oncogene protein market consists of sales of inhibitors, modulators, antibodies, and ribonucleic acid-based therapeutics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Myc Proto Oncogene Protein Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on myc proto oncogene protein market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for myc proto oncogene protein ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myc proto oncogene protein market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Myc Proto Oncogene Protein Market Characteristics
3. Myc Proto Oncogene Protein Market Trends And Strategies
4. Myc Proto Oncogene Protein Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Myc Proto Oncogene Protein Growth Analysis And Strategic Analysis Framework
5.1. Global Myc Proto Oncogene Protein PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Myc Proto Oncogene Protein Market Growth Rate Analysis
5.4. Global Myc Proto Oncogene Protein Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Myc Proto Oncogene Protein Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Myc Proto Oncogene Protein Total Addressable Market (TAM)
6. Myc Proto Oncogene Protein Market Segmentation
6.1. Global Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Recombinant Proteins
Polymerase Chain Reaction (PCR) Kits
Enzyme-Linked Immunosorbent Assay (ELISA) Kits
6.2. Global Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
BGA-003
ES-4000
Galarmin
Other Types
6.3. Global Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.4. Global Myc Proto Oncogene Protein Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Research
Diagnostics
Treatment Development
Biomarker Discovery
6.5. Global Myc Proto Oncogene Protein Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic And Research Institutions
Biotechnology Companies
Pharmaceutical Companies
Hospitals And Diagnostic Laboratories
6.6. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutic Monoclonal Antibodies
Diagnostic Monoclonal Antibodies
Research-Grade Monoclonal Antibodies
6.7. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Myc Proteins
Recombinant Fusion Proteins
Recombinant Antibody Fragments
6.8. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR) Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantitative PCR (Qpcr) Kits
Reverse Transcription PCR (Rt-Pcr) Kits
Digital PCR Kits
6.9. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Enzyme-Linked Immunoassay (ELISA) Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sandwich ELISA Kits
Competitive ELISA Kits
Indirect ELISA Kits
7. Myc Proto Oncogene Protein Market Regional And Country Analysis
7.1. Global Myc Proto Oncogene Protein Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Myc Proto Oncogene Protein Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Myc Proto Oncogene Protein Market
8.1. Asia-Pacific Myc Proto Oncogene Protein Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Myc Proto Oncogene Protein Market
9.1. China Myc Proto Oncogene Protein Market Overview
9.2. China Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Myc Proto Oncogene Protein Market
10.1. India Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Myc Proto Oncogene Protein Market
11.1. Japan Myc Proto Oncogene Protein Market Overview
11.2. Japan Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Myc Proto Oncogene Protein Market
12.1. Australia Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Myc Proto Oncogene Protein Market
13.1. Indonesia Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Myc Proto Oncogene Protein Market
14.1. South Korea Myc Proto Oncogene Protein Market Overview
14.2. South Korea Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Myc Proto Oncogene Protein Market
15.1. Western Europe Myc Proto Oncogene Protein Market Overview
15.2. Western Europe Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Myc Proto Oncogene Protein Market
16.1. UK Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Myc Proto Oncogene Protein Market
17.1. Germany Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Myc Proto Oncogene Protein Market
18.1. France Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Myc Proto Oncogene Protein Market
19.1. Italy Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Myc Proto Oncogene Protein Market
20.1. Spain Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Myc Proto Oncogene Protein Market
21.1. Eastern Europe Myc Proto Oncogene Protein Market Overview
21.2. Eastern Europe Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Myc Proto Oncogene Protein Market
22.1. Russia Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Myc Proto Oncogene Protein Market
23.1. North America Myc Proto Oncogene Protein Market Overview
23.2. North America Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Myc Proto Oncogene Protein Market
24.1. USA Myc Proto Oncogene Protein Market Overview
24.2. USA Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Myc Proto Oncogene Protein Market
25.1. Canada Myc Proto Oncogene Protein Market Overview
25.2. Canada Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Myc Proto Oncogene Protein Market
26.1. South America Myc Proto Oncogene Protein Market Overview
26.2. South America Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Myc Proto Oncogene Protein Market
27.1. Brazil Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Myc Proto Oncogene Protein Market
28.1. Middle East Myc Proto Oncogene Protein Market Overview
28.2. Middle East Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Myc Proto Oncogene Protein Market
29.1. Africa Myc Proto Oncogene Protein Market Overview
29.2. Africa Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Myc Proto Oncogene Protein Market Competitive Landscape And Company Profiles
30.1. Myc Proto Oncogene Protein Market Competitive Landscape
30.2. Myc Proto Oncogene Protein Market Company Profiles
30.2.1. Arvinas Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Arrakis Therapeutics Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.3. RayBiotech Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Erasca Incorporated Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Anima Biotech Incorporated Overview, Products and Services, Strategy and Financial Analysis
31. Myc Proto Oncogene Protein Market Other Major And Innovative Companies
31.1. RDP Pharma AG
31.2. Peptomyc Sociedad Limitada
31.3. Kintor Pharmaceutical Limited
31.4. Immunostep Biotech
31.5. Cothera Bioscience Proprietary Limited
31.6. Escend Pharmaceuticals Incorporated
31.7. Gibson Oncology Limited Liability Company
31.8. MecRx Proprietary Limited
31.9. Moleculin Biotech Incorporated
31.10. Escend Pharmaceuticals Incorporated
31.11. Linnane Pharma Aktiebolag
31.12. PYC Therapeutics Limited
31.13. Sapience Therapeutics Incorporated
31.14. Peptomyc Sociedad Limitad
31.15. Aptose Biosciences Incorporated
32. Global Myc Proto Oncogene Protein Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Myc Proto Oncogene Protein Market
34. Recent Developments In The Myc Proto Oncogene Protein Market
35. Myc Proto Oncogene Protein Market High Potential Countries, Segments and Strategies
35.1 Myc Proto Oncogene Protein Market In 2029 - Countries Offering Most New Opportunities
35.2 Myc Proto Oncogene Protein Market In 2029 - Segments Offering Most New Opportunities
35.3 Myc Proto Oncogene Protein Market In 2029 - Growth Strategies
